APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vascular Endothelial Growth Factor (VEGF) Antibodies

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Growth and Trends Forecast to 2032

31 December 2025106 pages

Choose your research edition.

Industry ResearchVascular Endothelial Growth Factor (VEGF) Antibodies Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Vascular Endothelial Growth Factor (VEGF) Antibodies Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Vascular Endothelial Growth Factor (VEGF) Antibodies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vascular Endothelial Growth Factor (VEGF) Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vascular Endothelial Growth Factor (VEGF) Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vascular Endothelial Growth Factor (VEGF) Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vascular Endothelial Growth Factor (VEGF) Antibodies include Sanofi, Novartis, Merck, Roche, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vascular Endothelial Growth Factor (VEGF) Antibodies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vascular Endothelial Growth Factor (VEGF) Antibodies market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vascular Endothelial Growth Factor (VEGF) Antibodies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vascular Endothelial Growth Factor (VEGF) Antibodies.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vascular Endothelial Growth Factor (VEGF) Antibodies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Company

Sanofi

Novartis

Merck

Roche

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Regeneron

Bristol-Myer Squibb

Boehringer Ingelheim

Abcam Plc

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Type

Aflibercept

Bevacizumab

Ranibizumab

Others

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Application

Specialty Clinics

Hospitals

Ambulatory Surgical Centers

Cancer Research Institutes

Others

Vascular Endothelial Growth Factor (VEGF) Antibodies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vascular Endothelial Growth Factor (VEGF) Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vascular Endothelial Growth Factor (VEGF) Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vascular Endothelial Growth Factor (VEGF) Antibodies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vascular Endothelial Growth Factor (VEGF) Antibodies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vascular Endothelial Growth Factor (VEGF) Antibodies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Aflibercept Table 2. Major Company of Bevacizumab Table 3. Major Company of Ranibizumab Table 4. Major Company of Others Table 5. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 7. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type (2021-2026) Table 8. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 9. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type (2021-2026) Table 10. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2021-2026) & (US$/Unit) Table 11. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (W Units) Table 12. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type (2027-2032) Table 13. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2027-2032) & (US$ Million) Table 14. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type (2027-2032) Table 15. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Type (2027-2032) & (US$/Unit) Table 16. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 17. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 19. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 23. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Type (2021-2026) & (US$ Million) Table 26. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Trends Table 27. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Drivers Table 28. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Opportunities and Challenges Table 29. Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Restraints Table 30. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue Market Share by Company (2021-2026) Table 32. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Company (2021-2026) & (W Units) Table 33. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Company (2021-2026) Table 34. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Major Company Production Sites and Headquarters Table 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Company, Product Type & Application Table 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Vascular Endothelial Growth Factor (VEGF) Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026) & (W Units) Table 43. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Region (2021-2026) Table 44. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2021-2026) & (US$ Million) Table 45. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Region (2021-2026) Table 46. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2027-2032) & (W Units) Table 48. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Region (2027-2032) Table 49. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Region (2027-2032) & (US$ Million) Table 50. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Region (2027-2032) Table 51. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 54. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application (2021-2026) Table 55. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 56. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application (2021-2026) Table 57. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2021-2026) & (US$/Unit) Table 58. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (W Units) Table 59. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application (2027-2032) Table 60. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2027-2032) & (US$ Million) Table 61. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application (2027-2032) Table 62. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Price by Application (2027-2032) & (US$/Unit) Table 63. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 64. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 66. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 70. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 77. Sanofi Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 87. Merck Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 92. Roche Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 102. Pfizer Recent Development Table 103. GlaxoSmithKline Company Information Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 107. GlaxoSmithKline Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 112. Bayer Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Regeneron Company Information Table 119. Regeneron Business Overview Table 120. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 122. Regeneron Recent Development Table 123. Bristol-Myer Squibb Company Information Table 124. Bristol-Myer Squibb Business Overview Table 125. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 127. Bristol-Myer Squibb Recent Development Table 128. Boehringer Ingelheim Company Information Table 129. Boehringer Ingelheim Business Overview Table 130. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 132. Boehringer Ingelheim Recent Development Table 133. Abcam Plc Company Information Table 134. Abcam Plc Business Overview Table 135. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio Table 137. Abcam Plc Recent Development Table 138. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 140. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2021-2026) Table 141. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032) & (W Units) Table 142. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Country (2027-2032) Table 143. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country (2021-2026) Table 146. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share Forecast by Country (2027-2032) Table 148. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 150. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2021-2026) Table 151. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032) & (W Units) Table 152. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country (2021-2026) Table 156. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 160. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032) & (W Units) Table 162. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country (2021-2026) Table 166. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share Forecast by Country (2027-2032) Table 168. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 169. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 170. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2021-2026) Table 171. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032) & (W Units) Table 172. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country (2021-2026) Table 176. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026) & (W Units) Table 180. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032) & (W Units) Table 182. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country (2021-2026) Table 186. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Vascular Endothelial Growth Factor (VEGF) Antibodies Distributors List Table 191. Vascular Endothelial Growth Factor (VEGF) Antibodies Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Vascular Endothelial Growth Factor (VEGF) Antibodies Image Figure 2. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size (2021-2032) & (US$ Million) Figure 4. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (2021-2032) & (W Units) Figure 5. Aflibercept Image Figure 6. Global Aflibercept Sales YoY Growth (2021-2032) & (W Units) Figure 7. Bevacizumab Image Figure 8. Global Bevacizumab Sales YoY Growth (2021-2032) & (W Units) Figure 9. Ranibizumab Image Figure 10. Global Ranibizumab Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Type 2025 VS 2032 Figure 15. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type in 2025 Figure 16. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type in 2025 Figure 17. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type in 2025 Figure 18. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type in 2025 Figure 21. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Antibodies Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Specialty Clinics Image Figure 28. Global Specialty Clinics Sales YoY Growth (2021-2032) & (W Units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (W Units) Figure 31. Ambulatory Surgical Centers Image Figure 32. Global Ambulatory Surgical Centers Sales YoY Growth (2021-2032) & (W Units) Figure 33. Cancer Research Institutes Image Figure 34. Global Cancer Research Institutes Sales YoY Growth (2021-2032) & (W Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Application 2025 VS 2032 Figure 39. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application in 2025 Figure 40. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application in 2025 Figure 41. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application in 2025 Figure 42. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application in 2025 Figure 45. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Market Share in Value by Application in 2025 Figure 49. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Vascular Endothelial Growth Factor (VEGF) Antibodies Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Vascular Endothelial Growth Factor (VEGF) Antibodies Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Aflibercept
  • Bevacizumab
  • Ranibizumab
  • Others
Applications
  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Regeneron
  • Bristol-Myer Squibb
  • Boehringer Ingelheim
  • Abcam Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Type
  6. 1.3.1 Aflibercept
  7. 1.3.2 Bevacizumab
  8. 1.3.3 Ranibizumab
  9. 1.3.4 Others
  10. 1.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Type
  11. 1.4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Trends
  2. 2.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Drivers
  3. 2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Opportunities and Challenges
  4. 2.4 Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vascular Endothelial Growth Factor (VEGF) Antibodies Revenue (2021-2026)
  2. 3.2 Global Top Players by Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (2021-2026)
  3. 3.3 Global Top Players by Vascular Endothelial Growth Factor (VEGF) Antibodies Price (2021-2026)
  4. 3.4 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Major Company Production Sites & Headquarters
  6. 3.6 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Company, Product Type & Application
  7. 3.7 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vascular Endothelial Growth Factor (VEGF) Antibodies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vascular Endothelial Growth Factor (VEGF) Antibodies Tier 1, Tier 2, and Tier 3
4 Vascular Endothelial Growth Factor (VEGF) Antibodies Regional Status and Outlook
  1. 4.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Historic Market Size by Region
  3. 4.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Forecasted Market Size by Region
  7. 4.3.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vascular Endothelial Growth Factor (VEGF) Antibodies by Application
  1. 5.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Market by Application
  2. 5.1.1 Specialty Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Ambulatory Surgical Centers
  5. 5.1.4 Cancer Research Institutes
  6. 5.1.5 Others
  7. 5.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Application
  8. 5.2.1 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Vascular Endothelial Growth Factor (VEGF) Antibodies Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Eli Lilly
  26. 6.5.1 Eli Lilly Company Information
  27. 6.5.2 Eli Lilly Business Overview
  28. 6.5.3 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Eli Lilly Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  30. 6.5.5 Eli Lilly Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Regeneron
  56. 6.10.1 Regeneron Company Information
  57. 6.10.2 Regeneron Business Overview
  58. 6.10.3 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Regeneron Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  60. 6.10.5 Regeneron Recent Developments
  61. 6.11 Bristol-Myer Squibb
  62. 6.11.1 Bristol-Myer Squibb Company Information
  63. 6.11.2 Bristol-Myer Squibb Business Overview
  64. 6.11.3 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bristol-Myer Squibb Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  66. 6.11.5 Bristol-Myer Squibb Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Abcam Plc
  74. 6.13.1 Abcam Plc Company Information
  75. 6.13.2 Abcam Plc Business Overview
  76. 6.13.3 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Abcam Plc Vascular Endothelial Growth Factor (VEGF) Antibodies Product Portfolio
  78. 6.13.5 Abcam Plc Recent Developments
7 North America by Country
  1. 7.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country
  2. 7.1.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026)
  4. 7.1.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  6. 7.2.1 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026)
  8. 7.2.3 North America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country
  2. 8.1.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026)
  4. 8.1.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  6. 8.2.1 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country
  2. 9.1.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  6. 9.2.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country
  2. 10.1.1 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026)
  4. 10.1.3 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  6. 10.2.1 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026)
  8. 10.2.3 South America Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country
  2. 11.1.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country
  6. 11.2.1 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Antibodies Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Value Chain Analysis
  2. 12.1.1 Vascular Endothelial Growth Factor (VEGF) Antibodies Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vascular Endothelial Growth Factor (VEGF) Antibodies Production Mode & Process
  7. 12.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vascular Endothelial Growth Factor (VEGF) Antibodies Distributors
  10. 12.2.3 Vascular Endothelial Growth Factor (VEGF) Antibodies Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst